621 related articles for article (PubMed ID: 35317831)
1. Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response.
Ashrafizadeh M; Paskeh MDA; Mirzaei S; Gholami MH; Zarrabi A; Hashemi F; Hushmandi K; Hashemi M; Nabavi N; Crea F; Ren J; Klionsky DJ; Kumar AP; Wang Y
J Exp Clin Cancer Res; 2022 Mar; 41(1):105. PubMed ID: 35317831
[TBL] [Abstract][Full Text] [Related]
2. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells.
Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N
Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210
[TBL] [Abstract][Full Text] [Related]
3. Blocked autophagy using lysosomotropic agents sensitizes resistant prostate tumor cells to the novel Akt inhibitor AZD5363.
Lamoureux F; Thomas C; Crafter C; Kumano M; Zhang F; Davies BR; Gleave ME; Zoubeidi A
Clin Cancer Res; 2013 Feb; 19(4):833-44. PubMed ID: 23258740
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA PRRT3-AS1 silencing inhibits prostate cancer cell proliferation and promotes apoptosis and autophagy.
Fan L; Li H; Wang W
Exp Physiol; 2020 May; 105(5):793-808. PubMed ID: 32086850
[TBL] [Abstract][Full Text] [Related]
5. Autophagy as a modulator and target in prostate cancer.
Farrow JM; Yang JC; Evans CP
Nat Rev Urol; 2014 Sep; 11(9):508-16. PubMed ID: 25134829
[TBL] [Abstract][Full Text] [Related]
6. Targeting tyrosine kinases and autophagy in prostate cancer.
Kung HJ
Horm Cancer; 2011 Feb; 2(1):38-46. PubMed ID: 21350583
[TBL] [Abstract][Full Text] [Related]
7. Phytochemicals in Inhibition of Prostate Cancer: Evidence from Molecular Mechanisms Studies.
Hao Q; Wu Y; Vadgama JV; Wang P
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139145
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment.
Yoshida GJ
J Hematol Oncol; 2017 Mar; 10(1):67. PubMed ID: 28279189
[TBL] [Abstract][Full Text] [Related]
9. PAWR-mediated suppression of BCL2 promotes switching of 3-azido withaferin A (3-AWA)-induced autophagy to apoptosis in prostate cancer cells.
Rah B; ur Rasool R; Nayak D; Yousuf SK; Mukherjee D; Kumar LD; Goswami A
Autophagy; 2015; 11(2):314-31. PubMed ID: 25803782
[TBL] [Abstract][Full Text] [Related]
10. AMPK-mediated autophagy is a survival mechanism in androgen-dependent prostate cancer cells subjected to androgen deprivation and hypoxia.
Chhipa RR; Wu Y; Ip C
Cell Signal; 2011 Sep; 23(9):1466-72. PubMed ID: 21554950
[TBL] [Abstract][Full Text] [Related]
11. Diindolylmethane and its halogenated derivatives induce protective autophagy in human prostate cancer cells via induction of the oncogenic protein AEG-1 and activation of AMP-activated protein kinase (AMPK).
Draz H; Goldberg AA; Titorenko VI; Tomlinson Guns ES; Safe SH; Sanderson JT
Cell Signal; 2017 Dec; 40():172-182. PubMed ID: 28923415
[TBL] [Abstract][Full Text] [Related]
12. PKM2 Knockdown Induces Autophagic Cell Death via AKT/mTOR Pathway in Human Prostate Cancer Cells.
Dey P; Kundu A; Sachan R; Park JH; Ahn MY; Yoon K; Lee J; Kim ND; Kim IS; Lee BM; Kim HS
Cell Physiol Biochem; 2019; 52(6):1535-1552. PubMed ID: 31135122
[TBL] [Abstract][Full Text] [Related]
13. Flubendazole elicits anti-cancer effects via targeting EVA1A-modulated autophagy and apoptosis in Triple-negative Breast Cancer.
Zhen Y; Zhao R; Wang M; Jiang X; Gao F; Fu L; Zhang L; Zhou XL
Theranostics; 2020; 10(18):8080-8097. PubMed ID: 32724459
[No Abstract] [Full Text] [Related]
14. Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy.
Gaur S; Wen Y; Song JH; Parikh NU; Mangala LS; Blessing AM; Ivan C; Wu SY; Varkaris A; Shi Y; Lopez-Berestein G; Frigo DE; Sood AK; Gallick GE
Oncotarget; 2015 Oct; 6(30):29161-77. PubMed ID: 26313360
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of FBP1 enhances radiosensitivity in prostate cancer cells by activating autophagy.
Li XR; Zhou KQ; Yin Z; Gao YL; Yang X
Neoplasma; 2020 Sep; 67(5):982-991. PubMed ID: 32453596
[TBL] [Abstract][Full Text] [Related]
16. Ubenimex inhibits cell proliferation, migration and invasion by inhibiting the expression of APN and inducing autophagic cell death in prostate cancer cells.
Wang X; Niu Z; Jia Y; Cui M; Han L; Zhang Y; Liu Z; Bi D; Liu S
Oncol Rep; 2016 Apr; 35(4):2121-30. PubMed ID: 26846372
[TBL] [Abstract][Full Text] [Related]
17. Eriocalyxin B Induces Apoptosis and Autophagy Involving Akt/Mammalian Target of Rapamycin (mTOR) Pathway in Prostate Cancer Cells.
Yu Z; Chen Y; Liang C
Med Sci Monit; 2019 Nov; 25():8534-8543. PubMed ID: 31714902
[TBL] [Abstract][Full Text] [Related]
18. Targeting androgen receptor leads to suppression of prostate cancer via induction of autophagy.
Jiang Q; Yeh S; Wang X; Xu D; Zhang Q; Wen X; Xia S; Chang C
J Urol; 2012 Oct; 188(4):1361-8. PubMed ID: 22906664
[TBL] [Abstract][Full Text] [Related]
19. Roles of autophagy induced by natural compounds in prostate cancer.
Naponelli V; Modernelli A; Bettuzzi S; Rizzi F
Biomed Res Int; 2015; 2015():121826. PubMed ID: 25821782
[TBL] [Abstract][Full Text] [Related]
20. Rational targeting of autophagy in colorectal cancer therapy: From molecular interactions to pharmacological compounds.
Jin C; Wang T; Yang Y; Zhou P; Li J; Wu W; Lv X; Ma G; Wang A
Environ Res; 2023 Jun; 227():115721. PubMed ID: 36965788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
